Delayed therapy with curative intent in a contemporary prostate cancer watchful-waiting cohort [5]

BJU International

Volumn 94, Issue 9, 2004, Pages 1401-1402

  Okamoto, Hiroshi ^a,b   Terai, Chihiro ^a,b   Kamatani, Naoyuki ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b Sacravia Clinic   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AGED; CANCER SURVIVAL; FOLLOW UP; HORMONAL THERAPY; HUMAN; LETTER; LUNG CANCER; MALE; MORTALITY; NEEDLE BIOPSY; PENIS CANCER; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; RECURRENT CANCER; TUMOR CELL;

EID: 11144233376     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2004.05224_5.x     Document Type: Letter

References (3)

1. El-Geneidy M, Garzotto M, Panagiotou I et al. Delayed therapy with curative intent in a contemporary prostate cancer watchful-waiting cohort. BJU Int 2004; 93: 510-5
2. Pound CR, Partin AW, Eisenberger MA et al. Natural history of progression after PSA elevation following radical prostatectomy. JAMA 1999; 281: 1591-7
3. D'Amico AV, Chen MH, Roehl KA et al. Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy. N Engl J Med 2004; 351: 125-35